William B. Horne - 14 Jun 2021 Form 3 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ William B. Horne
Issuer symbol
ALZN
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
3
Filing time
14 Jun 2021, 19:55:58 UTC
Previous filing
11 Jun 2021
Next filing
24 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALZN Stock Options (Right to Buy) 14 Jun 2021 Common Stock 2,500,000 $0.004000 Direct F1
holding ALZN Stock Options (Right to Buy) 14 Jun 2021 Common Stock 250,000 $1.50 Direct F2
holding ALZN Stock Options (Right to Buy) 14 Jun 2021 Common Stock 250,000 $1.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Horne was granted stock options to purchase 2,500,000 shares of Common Stock, which options are exercisable at an exercise price of $0.004 and are currently vested and exercisable.
F2 Mr. Horne was granted stock options to purchase 250,000 shares of Common Stock, which options are exercisable at an exercise price of $1.50 per share, and vest ratably over thirty-six (36) months beginning on the date of grant. Of these options, 125,000 shares of Common Stock are vested and exercisable.
F3 Mr. Horne was granted performance-based stock options to purchase 250,000 shares of Common Stock, which options are exercisable for a period of ten (10) years at an exercise price of $1.50 per share. Of these options, no shares of Common Stock are vested and exercisable.